A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy;Ein modifiziertes ultra-rush-verfahren der spezifischen immuntherapie bei kindern und jugendlichen mit einer insektengiftallerqie

Klinische Padiatrie

Volumn 216, Issue 2, 2004, Pages 79-82

  Steiss J O ^a   Huls G ^a   Gortner, L ^a   Lindemann, H ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Allergen immunotherapy; Hyposensitization; Insect venom allergy; Ultra rush protocol

Indexed keywords

ALLERGEN; INSECT VENOM;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DESENSITIZATION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; INSECT VENOM ALLERGY; LENGTH OF STAY; MALE; PATIENT COMPLIANCE; PREVALENCE; PROTECTION; SKIN INFLAMMATION; URTICARIA;

ADOLESCENT; BEE VENOMS; CHILD; DELAYED-ACTION PREPARATIONS; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INJECTIONS, SUBCUTANEOUS; INSECT BITES AND STINGS; MALE; PATIENT ADMISSION; TREATMENT OUTCOME; WASP VENOMS;

EID: 1842637212     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-44893     Document Type: Article

References (16)

1. Birnbaum J, Ramadour M, Magnan A, Vervloet D. Hymenoptera ultrarush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy 2003; 33: 58-64
2. Brehler R, Wolf H, Kütting B, Schnitker J, Luger T. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 2000; 105: 1231-1235
3. Bousquet J, Lockey RF, Malling H-J. WHO Position Paper Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44): 1-42
4. Bucher C, Schwager S, Schmid-Grendelmeier P, Wüthrich B. Sicherheit der Ultrarush-Hyposensibilisierung mit Bienen- und Wespengift. Allergo J 2003; 12: 562-565
5. Golden DBK, Kwitreovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol 1996; 97: 579-587
6. Handke RP, Rosewich M, Bez C, Zielen S. Ultra-Rush-Insektengift- Hyposensibilisierung im Kindesalter - eine sichere und verträgliche Methode. Monatsschr Kinderheilkd 2002; 3: 406
7. Jung A, Schill W-B. Verlaufsparameter zur Hyposensibilisierung bei Hymenopterengiftallergie. Z Hautkr 2002; 77: 241-244
8. Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Lepp U, Niggemann B, Rakoski J, Renz H, Saloga J, Simon J. Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen. Allergo J 2000; 9: 317-324
9. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966; 3: 331-333
10. Przybilla B, Ring J, Rieger B. Die Indikation zur Hymenopterengift- Hyposensibilisierung kann nicht anhand eines diagnostischen Parameter bewertenden Punkteschemas gestellt werden. Allergologie 1992; 13: 114-119
11. Ruëff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 2001; 108: 1027-1032
12. Ruëff F, Przybilla B, Fuchs T, Gall H, Rakoski J, Stolz W, Vieluf D. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo J 2000; 9: 458-472
13. Ruëff F, Przybilla B. Ungerechtfertigte Abbrüche der Bienengift-Hyposensiblisierung. Allergo J 2002; 11: 104-108
14. Schuetze GE, Forster J, Hauk PJ, Friedl K, Kuehr J. Bee-venom allergy in children: Long-term predictive value of standardized challenge tests. Pediatr Allergy Immunol 2002; 13: 18-23
15. Urbanek R. Insektengiftallergie. Pädiat Prax 2000; 58: 413-440
16. van der Zwan JC, Flinterman J, Jankowski IG, Kerckhaert JAM. Hyposensitization to wasp venom in six hours. Br Med J 1983; 287: 1329-1331